Imidazo bicyclic imminium compounds as antitumor agents

standard

posted on 2023-02-05, 04:29 authored by Alison Ondrus, James Chen, Tomoyo Kato

No description supplied

Funding

CHRI Postdoctoral Fellowship | Funder: Stanford Child Health Research Institute

Development of Gli1-Selective Therapeutics for Hedgehog Pathway-Dependent Cancers | Funder: National Cancer Institute | Grant ID: F32CA183527

History

Usage metrics

Categories

No categories selected

Keywords

Uncategorised value

Licence

Exports